• 1.1 The Role of Contrast
• 1.2 Use by Modality
  • 1.2.1 X-Ray and CT
  • 1.2.2 Ultrasound
  • 1.2.3 MRI
  • 1.2.4 Radiopharmaceuticals
  
  
• 1.3 World Market Summary
  • 1.3.1 Market Drivers
  • 1.3.2 Market Challenges
  • 1.3.3 World Market Growth Analysis
  
  
• 1.4 Methodology

Chapter Two: Introduction

• 2.1 Overview
• 2.2 Perspective
• 2.3 Key Markets for Contrast Agents
  • 2.3.1 Radiography (X-Ray) and Computed Tomography (CT)
  • 2.3.2 Ultrasound
  • 2.3.3 Magnetic Resonance Imaging (MRI)
  • 2.3.4 Nuclear Medicine
  • 2.3.4.1 Positron Emission Tomography (PET)
  • 2.3.4.2 Single Photon Emission Computed Tomography SPECT
  • 2.3.4.3 Gamma Cameras
  
  
• 2.4 Ionic and Non-Ionic Contrast Agents
• 2.5 Issues and Challenges
  • 2.5.1 Adverse Events
  • 2.5.2 Therapeutic Monitoring
  • 2.5.3 Drug Delivery and Image Guided Interventions
  • 2.5.4 Whole Body Screening
  • 2.5.5 Technology Development
  • 2.5.6 Combination Technology

Chapter Three: Promising Developments

• 3.1 Nuclear Imaging for Appendicitis
• 3.2 PET for Alzheimer’s
• 3.3 Contrast-Enhanced MRI Mammogram
• 3.4 Combined Contrast Enhanced MRI
• 3.5 Contrast Angiography
• 3.6 Avoiding Multiple MRIs
• 3.7 Chemical Shift Imaging
• 3.8 Perfusion CT
• 3.9 Multimodal Contrast

Chapter Four: Markets

• 4.1 Market Drivers
  • 4.1.1 Targeted Imaging
  • 4.1.2 The Promise of Increased Diagnostic Efficacy
  • 4.1.3 Older Population
  • 4.1.4 System Upgrades
  
  
• 4.2 Procedures and Reimbursement
• 4.3 Market Size and Outlook for Contrast Media
  • 4.3.1 Agents in Development
  • 4.3.2 Total Market Size and Forecast
  • 4.3.3 Segment Market Forecasts
  • 4.3.3.1 Radiography (X-Ray)
  • 4.3.3.2 Computed Tomography (CT)
  • 4.3.3.3 Ultrasound
  • 4.3.3.4 Magnetic Resonance Imaging (MRI)
  
  
• 4.4 Market Size and Outlook for Molecular Imaging Agents
  • 4.4.1 Products and Development
  • 4.4.2 Market Forecast
  
  
• 4.5 Competitive Positions

Chapter Five: Company Profiles

• Acusphere Inc.
• Advanced Magnetics Inc.
• ART Advanced Research Technologies Inc.
• Bristol-Myers Squibb
• Boston Life Sciences
• Bracco SpA
• Cell Point
• Cytogen Corp.
• Daiichi Pharmaceutical Co. Ltd.
• Dendritic NanoTechnologies Inc.
• Dowpharma
• Draximage
• Epix Pharmaceuticals Inc.
• E-Z-EM Inc.
• GE Healthcare
• Guerbet Group
• Hovione FarmaCiencia SA
• Imcor Pharmaceutical Co.
• Immunomedics Inc.
• King Pharmaceuticals Inc.
• Luna nanoWorks
• Macrocyclics
• Mallinckrodt
• Palatin Technologies Inc.
• Pharmacyclics
• Point Biomedical Corp.
• Schering AG

List of Exhibits

Chapter One: Executive Summary

• Exhibit 1: Market Summary: World Market for Medical Contrast Media 2006-2010

Chapter Two: Introduction

• Exhibit 2: Key Medical Contrast Agents by Type
• Exhibit 3: Advantages of Non-Ionic Contrast Media

Chapter Four: Markets

• Exhibit 4: Estimated Worldwide Medical X-Ray Procedure Volume by Region (U.S., E.U., ROW) 2005
• Exhibit 5: Estimated Worldwide Medical MRI Procedure Volume by Region (U.S., E.U., ROW) 2005
• Exhibit 6: Estimated Worldwide Medical CT Procedure Volume by Region (U.S., E.U., ROW) 2005
• Exhibit 7: Estimated Worldwide Medical PET Procedure Volume by Region (U.S., E.U., ROW) 2005
• Exhibit 8: Estimated Percentage of Imaging Procedures Employing Contrast Agents by Modality (X-Ray, CT, MRI, Ultrasound, PET, SPECT)
• Exhibit 9: Status of Selected Medical Imaging Agents in Development (Company, Product, Status)
• Exhibit 10: World Market for Medical Contrast Media and Radiopharmaceuticals 2005-2010
• Exhibit 11: World Market Share for Medical Contrast Media and Radiopharmaceuticals by Modality (CT, MRI, PET, SPECT, Ultrasound, X-Ray), 2006
• Exhibit 12: World Market Share for Medical Contrast Media and Radiopharmaceuticals by Modality (CT, MRI, PET, SPECT, Ultrasound, X-Ray), 2010
• Exhibit 13: World Market for X-Ray Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
• Exhibit 14: World Market for Medical X-Ray Contrast Media by Geographic Segment
• Exhibit 15: World Market for CT Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
• Exhibit 16: World Market for Medical CT Contrast Media by Geographic Segment
• Exhibit 17: World Market for Ultrasound Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
• Exhibit 18: World Market for Medical Ultrasound Contrast Media by Geographic Segment
• Exhibit 19: World Market for MRI Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
• Exhibit 20: World Market for Medical MRI Contrast Media by Geographic Segment
• Exhibit 21: World Market for PET Radiopharmaceuticals by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
• Exhibit 22: World Market for Medical PET Radiopharmaceuticals by Geographic Segment
• Exhibit 23: World Market for SPECT Radiopharmaceuticals by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
• Exhibit 24: World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment
• Exhibit 25: Key Players’ Shares of the Worldwide Medical Contrast Media Market, 2005